发明名称 Enhanced triple-helix and double-helix formation directed by oligonucleotides containing modified pyrimidines
摘要 Novel oligomers are disclosed which have enhanced ability with respect to forming duplexes or triplexes compared with oligomers containing only conventional bases. The oligomers contain the base analog 5-propynyluracil, 5-propynylcytosine or related analogs. The oligomers of the invention are capable of (i) forming triplexes with various target sequences such as virus or oncogene sequences by coupling into the major groove of a target DNA duplex at physiological pH or (ii) forming duplexes by binding to single-stranded DNA or to RNA encoded by target genes. The oligomers of the invention may be constructed to have any desired sequence, provided the sequence normally includes one or more bases that is replaced with the analogs of the invention. Compositions of the invention can be used for diagnostic purposes in order to detect viruses or disease conditions.
申请公布号 US6235887(B1) 申请公布日期 2001.05.22
申请号 US19940338352 申请日期 1994.11.14
申请人 ISIS PHARMACEUTICALS, INC. 发明人 FROEHLER BRIAN;JONES ROBERT J.
分类号 C07H19/06;C07H19/10;C07H19/20;C07H21/00;C12Q1/68;H04L12/24;(IPC1-7):C07H21/02;A01N43/04 主分类号 C07H19/06
代理机构 代理人
主权项
地址